GENE ONLINE|News &
Opinion
Blog

2023-01-18| In-DepthSpecial

Moving Beyond COVID With mRNA Technology

by Reed Slater
Share To
The Future of mRNA Technology panel hosted during JP Morgan Healthcare Conference Week 2023
After playing a critical role in developing new vaccine technology to help manage the COVID-19 pandemic, all eyes are on mRNA and its massive potential in various other applications. At the 2023 JP Morgan Healthcare Conference, the Penn Center for Innovation held a panel with three industry professionals with close ties to mRNA technology to discuss the future of the technology and its unfettered potential in a rapidly evolving environment.
The panel, titled “The Future of mRNA Technology,” included the co-discoverer of mRNA technology and fundamental figure in developing Pfizer and BioNTech’s COVID-19 vaccine, Katalin Kariko, Ph.D. Michael J. Mitchell, Ph.D., a drug delivery expert who worked alongside Moderna co-founder Robert Langer, also joined the panel. The third panel member was passionate scientist Laura Shawver, Ph.D., who is currently the CEO of a Penn State spinout company, Capstan Therapeutics. Renowned industry expert and Founding Managing Director of Westlake Village Partners, Beth Seidenberg, MD, moderated the panel. 

It's free! Log in now to read

LATEST
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Scientists Study Imaging Probes in First-Ever Amputated Human Limb Model
2023-01-16
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Bayer Signs Up To Google Cloud To Boost Drug Discovery
2023-01-13
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!